SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-048539
Filing Date
2015-06-01
Accepted
2015-06-01 20:11:54
Documents
2
Period of Report
2015-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4163
2 POA DOCUMENT poa.txt EX-24.4_586691 1565
  Complete submission text file 0001209191-15-048539.txt   7413
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O ANTARES PHARMA INC 707 EAGLEVIEW BLVD SUITE 414 EXTON PA 19341
Business Address
GONELLA JACQUES (Reporting) CIK: 0001189296 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 15905046